106 related articles for article (PubMed ID: 16280653)
1. Peptide-mediated immunosuppression.
Zang W; Murphy B
Am J Ther; 2005; 12(6):592-9. PubMed ID: 16280653
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides.
Murphy B; Yu J; Jiao Q; Lin M; Chitnis T; Sayegh MH
J Am Soc Nephrol; 2003 Apr; 14(4):1053-65. PubMed ID: 12660341
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of oral tolerance by MHC peptides.
Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
Ann N Y Acad Sci; 1996 Feb; 778():338-45. PubMed ID: 8610987
[TBL] [Abstract][Full Text] [Related]
5. MHC Class II-mediated apoptosis by a nonpolymorphic MHC Class II peptide proceeds by activation of protein kinase C.
Zang W; Kalache S; Lin M; Schroppel B; Murphy B
J Am Soc Nephrol; 2005 Dec; 16(12):3661-8. PubMed ID: 16221866
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
7. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7762-6. PubMed ID: 1502196
[TBL] [Abstract][Full Text] [Related]
8. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
[TBL] [Abstract][Full Text] [Related]
9. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
10. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
11. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide.
Zang W; Lin M; Kalache S; Zhang N; Krüger B; Waaga-Gasser AM; Grimm M; Hancock W; Heeger P; Schröppel B; Murphy B
J Immunol; 2008 Dec; 181(11):7499-506. PubMed ID: 19017939
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
[TBL] [Abstract][Full Text] [Related]
14. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
Rider BJ; Fraga E; Yu Q; Singh B
Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
[TBL] [Abstract][Full Text] [Related]
17. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.
Murphy B; Akalin E; Watschinger B; Carpenter CB; Sayegh MH
Transplant Proc; 1995 Feb; 27(1):409-10. PubMed ID: 7879041
[No Abstract] [Full Text] [Related]
20. Human HLA-DQ beta chain presents minor lymphocyte stimulating locus gene products and clonally deletes TCR V beta 6+, V beta 8.1+ T cells in single transgenic mice.
Zhou P; Anderson GD; Savarirayan S; Inoko H; David CS
Hum Immunol; 1991 May; 31(1):47-56. PubMed ID: 1908840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
